Researchers used a SYNERGIC Trial to evaluate the efficacy of a combination of cognitive training, progressive exercise, and vitamin D supplementation on reversing the effects of mild cognitive impairment in adults
ESMO 2023: MSD’s Welireg leads HIF-2α inhibitors in RCC despite unclear OS – Pharmaceutical Technology
Welireg was reported to have a well-tolerated safety profile similar to that of Afinitor while having a longer time to function deterioration for better patient